/
Plan/
Barriers & Mitigation StrategiesHome
About DAC-SP
Early Detection Blueprint
Case Studies
Grant Recipients
Resource Index
US Fellowship RFI
Contact
Plan
Here are five potential barriers you may encounter as you plan for implementation, and mitigation strategies for addressing these barriers.
Barrier
1
The value of early detection for cognitive impairment is often a subject of misalignment for healthcare systems. Many systems and providers have diverse perspectives on diagnostic tools, care pathways, and treatment options. Additionally, stigma surrounding cognitive impairment, Alzheimer’s disease, and related dementias can discourage patients from reporting symptoms and seeking testing.
Moreover, many healthcare systems have historically been organized around acute care and crisis management, so it is challenging to shift to a preventive approach for early detection of cognitive impairment. While there might not yet be global consensus on how to best approach early detection, there are steps that can be taken to help improve care across all healthcare systems.
Mitigation Strategy
Barrier
2
In healthcare systems where ongoing funding is not guaranteed, the program may require buy-in and commitment from funders. This is also closely related to raising awareness about the importance of building an early detection program.
Mitigation Strategy
Barrier
3
Ensuring the equity of access to and delivery of the early detection program for cognitive impairment is an important consideration that may directly impact the patient population. Patient access issues can be driven by many factors such as language, ethnicity, socioeconomic status, health status, and location.
Mitigation Strategy
Barrier
4
Most healthcare systems are familiar with optimizing and improving existing care pathways. However, in many cases, an early detection program for cognitive impairment is a novel care pathway that requires significant capability-building.
Mitigation Strategy
Barrier
5
Healthcare systems may face challenges in introducing new cognitive assessment tools to their system. A lack of clinical consensus or precedent for the use of these novel tools may lead to resistance to their adoption, or a lack of reimbursement methods for specific tools, or challenges with procurement.
Mitigation Strategy
Plan
5
Healthcare systems may face challenges in introducing new cognitive assessment tools to their system. A lack of clinical consensus or precedent for the use of these novel tools may lead to resistance to their adoption, or a lack of reimbursement methods for specific tools, or challenges with procurement.
Engage the support of scientific, academic, operations, legal, and procurement experts to address this challenge. The introduction of a novel tool will require validation and multi-level, change-management support from your core leadership team and across stakeholders.
Plan
4
Most healthcare systems are familiar with optimizing and improving existing care pathways. However, in many cases, an early detection program for cognitive impairment is a novel care pathway that requires significant capability-building.
Build organizational capacity and buy-in for the program with sufficient time and targeted support by leveraging the champions’ expertise.
Plan
3
Ensuring the equity of access to and delivery of the early detection program for cognitive impairment is an important consideration that may directly impact the patient population. Patient access issues can be driven by many factors such as language, ethnicity, socioeconomic status, health status, and location.
Understand the target community's needs in terms of language, cultural sensitivities and health literacy around cognitive impairment and Alzheimer’s disease. Based on your findings, determine what needs to be modified in the current practice.
Plan
2
In healthcare systems where ongoing funding is not guaranteed, the program may require buy-in and commitment from funders. This is also closely related to raising awareness about the importance of building an early detection program.
Securing funding for an early detection program for cognitive impairment requires various approaches across all phases of the work. It is essential to set an expectation with key stakeholders regarding the long-term benefits for the healthcare system and the target population.
Plan
1
The value of early detection for cognitive impairment is often a subject of misalignment for healthcare systems. Many systems and providers have diverse perspectives on diagnostic tools, care pathways, and treatment options. Additionally, stigma surrounding cognitive impairment, Alzheimer’s disease, and related dementias can discourage patients from reporting symptoms and seeking testing.
Moreover, many healthcare systems have historically been organized around acute care and crisis management, so it is challenging to shift to a preventive approach for early detection of cognitive impairment. While there might not yet be global consensus on how to best approach early detection, there are steps that can be taken to help improve care across all healthcare systems.
People will have different perspectives on the value of early detection depending on their role or experiences. It is crucial to understand the knowledge gaps so training programs can be structured in an effective way.